Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography

Ophthalmic Surgery Lasers and Imaging

Volumn 34, Issue 3, 2003, Pages 251-258

  So, Scott C ^a   Hedges, Thomas R ^b,c   Schuman, Joel S ^b   Quireza, Maria Luz Amaro ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c Box 450 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; ANTIRHEUMATIC AGENT; DERMATOLOGICAL AGENT;

ADULT; AGED; ARTICLE; AUTOANALYSIS; CENTRAL SCOTOMA; CLINICAL ARTICLE; ELECTRORETINOGRAPHY; EVALUATION; EYE PHOTOGRAPHY; FLUORESCENCE ANGIOGRAPHY; HIGH RISK PATIENT; HUMAN; OPHTHALMOSCOPY; PATIENT MONITORING; PRIORITY JOURNAL; RETINA FOVEA; RETINOPATHY; VISUAL ACUITY; VISUAL FIELD; VISUAL FIELD DEFECT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RETINA; RETINA DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; DERMATOLOGIC AGENTS; ELECTRORETINOGRAPHY; HUMANS; HYDROXYCHLOROQUINE; MIDDLE AGED; RETINA; RETINAL DISEASES; VISUAL ACUITY; VISUAL FIELDS;

EID: 77949854464     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/1542-8877-20030501-20     Document Type: Article

References (25)

1. Weinberg DV. Retina and vitreous: trauma: toxic retinopathies. In: Yanoff M, Duker JS, eds. Ophthalmology. St. Louis, MO: Mosby; 1999:8.46.1-8.46.2.
2. Hobbs HE, Sorsby A, Freedman A. Retinopathy following chloroquine therapy. Lancet. 1959;2:478-480.
3. Okun E, Gouras P, Bernstein H, Von Sallman L. Chloroquine retinopathy. Arch Ophthalmol. 1963;69: 59-71.
4. Finbloom D, Silver K, Newsome DA, Gunkel R. Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity. J Rheumatol. 1985;12:692-694.
5. Johnson MW, Vine AK. Hydroxychloroquine therapy in massive total doses without retinal toxicity. Am J Ophthalmol. 1987;104:139-144.
6. Bernstein HN. Ocular safety of hydroxychloroquine. Ann Ophthalmol. 1991;23:292-296.
7. Rynes RI, Krohel G, Falbo A, Reinecke RD, Wolfe B, Bartholomew LE. Ophthalmologic safety of long-term hydroxychloroquine treatment. Arthritis Rheum. 1979; 22:832-836.
8. Ruiz RS, Saatci OA. Chloroquine and hydroxychloroquine retinopathy: how to follow affected patients. Ann Ophthalmol. 1991;23:290-291.
9. Easterbrook M. Is corneal deposition of antimalarial any indication of retinal toxicity? Can J Ophthalmol. 1990;25:249-251.
10. Morsman CDG, Livesey SJ, Richards IM, Jessop JD, Mills PV. Screening for hydroxychloroquine retinal toxicity: is it necessary? Eye. 1990;4:572-576.
11. Easterbrook M. Ocular effects and safety of antimalarial agents. Am J Med. 1988;85(suppl 4A):23-29.
12. Weiner A, Sandberg MA, Gaudio AR, Kini MM, Berson EL. Hydroxychloroquine retinopathy. Am J Ophthalmol. 1991;112:528-534.
13. Sutter EE, Tran D. The field topography of ERG components in man: I. The photopic luminance response. Vis Res. 1992;32:433-446.
14. Maturi RK, Folk JC, Nichols B, Oetting TT, Kardon RH. Hydroxychloroquine retinopathy. Arch Ophthalmol. 1999;117:1262-1263.
15. Bernstein HN, Ginsberg J. The pathology of chloroquine retinopathy. Arch Ophthalmol. 1964;71:238-245.
16. Mushinski JF, Yielding KL, Munday JS. A comparison of the in vitro effects of steroid hormones and certain antimalarial compounds. Arthritis Rheum. 1962;5:118.
17. Wright CI, Sabine J. Cholinesterases of human erythrocytes and plasma and their inhibition by antimalarial drugs. Pharmacology and Experimental Therapeutics. 1948;93:230-239.
18. Cruess AF, Schachat AP, Nicholl J, Augsburger JJ. Chloroquine retinopathy: is fluorescein angiography necessary? Ophthalmology. 1985;92:1127-1129.
19. Bishara SA, Matamoros N. Evaluation of several tests in screening for chloroquine maculopathy. Eye. 1989;3:777-782.
20. Percival SP, Behrman J. Ophthalmological safety of chloroquine. Br J Ophthalmol. 1969;53:101-109.
21. Sassaman FW, Cassidy JT, Alpern M, Maaseidvaag E. Electroretinography in patients with connective tissue diseases treated with hydroxychloroquine. Am J Ophthalmol. 1970;70:515-523.
22. Palmowski AM, Sutter EE, Bearse MA Jr, Fung W. Mapping of retinal function in diabetic retinopathy using the multifocal electroretinogram. Invest Ophthalmol Vis Sci. 1997;38:2586-2596.
23. Bearse MA Jr, Sutter EE. Imaging localized retinal dysfunction with the multifocal electroretinogram. J Opt Soc Am A. 1996;13:634-640.
24. Hood DC, Holopigian K, Greenstein V, et al. Assessment of local retinal function in patients with retinitis pigmentosa using the multi-focal ERG technique. Vis Res. 1998;38:163-179.
25. Marmor MF, Tan F. Central serous chorioretinopathy: bilateral multifocal electroretinographic abnormalities. Arch Ophthalmol. 1999;117:184-188.